Sort
30,917 grants matching “tumor microenvironment”
Understanding IDH mutant gliomas
$607,784Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
$607,771Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
$607,766Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Effect of Th2-type microenvironment on CD8 TRM-mediated protection from infection
$607,611Shannon K Bromley · Massachusetts General Hospital · R01 · FY2024 · AI
Identifying and exploiting molecular abnormalities of tumor vasculature
$607,580Michael Clark Oldham · University Of California, San Francisco · R01 · FY2025 · CA
Single-cell characterization of tumor and microenvironment co-evolution in Peripheral T-cell Lymphomas
$607,500Raul Rabadan · Columbia University Health Sciences · U01 · FY2020 · CA
Single-cell characterization of tumor and microenvironment co-evolution in Peripheral T-cell Lymphomas
$607,499Raul Rabadan · Columbia University Health Sciences · U01 · FY2021 · CA
Single-cell characterization of tumor and microenvironment co-evolution in Peripheral T-cell Lymphomas
$607,498Raul Rabadan · Columbia University Health Sciences · U01 · FY2019 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$607,228Gerald V Denis · Boston University Medical Campus · R01 · FY2022 · CA
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
$607,221Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer
$607,181Rong Zhou · University Of Pennsylvania · U24 · FY2021 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer
$607,181Rong Zhou · University Of Pennsylvania · U24 · FY2020 · CA
Applying pathomics to establish a biosignature for aggressive skin melanoma
$607,163Yvonne Margaret Saenger · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Immunotherapy via engineered therapeutic programs in tumors using RNA
$607,159Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2024 · CA
A phase I/II study of combined therapy with Th17-inducing dendritic cells and pembrolizumab in patients with recurrent epithelial ovarian cancer
$607,154Keith L Knutson · Mayo Clinic Jacksonville · R01 · FY2024 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$607,124Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2022 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis
$607,045Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Tumor Suppressor Protein, p53
$607,008Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Cancer Immunotherapy Clinical Trials
$607,000Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Novel dietary interventions for reducing obesity-associated breast cancer
$606,900Paul S Maclean · University Of Colorado Denver · R01 · FY2022 · CA
Non-invasive imaging of the anti-tumor immune response
$606,892Hidde L Ploegh · Boston Children'S Hospital · R01 · FY2021 · CA
The role of microbiota amino acid metabolism in cancer
$606,839Chun-Jun Guo · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
An automated high-throughput tissue model for screening metastatic effectors
$606,813David J Beebe · University Of Wisconsin-Madison · R01 · FY2019 · CA
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$606,797Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption
$606,729Katja A Lamia · Scripps Research Institute, The · R01 · FY2025 · CA